[1] 黄洪琳, 易斌. 长期住院老年患者下呼吸道感染病原菌分布及耐药性分析[J]. 实用预防医学, 2017,24(4):76-79. [2] 祝俊英,王春, 孙燕,等. 儿童患者中分离的碳青霉烯类耐药肺炎克雷伯菌 分子流行病学分析及耐药机制研究[J]. 中国感染与化疗杂志, 2016,16(5):578-582. [3] 胡咏梅,邹明祥,李军,等.同一患者不同部位分离耐碳青霉烯类肺炎克雷伯菌耐药机制研究及同源性分析[J]. 临床检验杂志, 2017,35(7):511-517. [4] Lee BY, Bartsch SM, Wong KF, et al.The potential trajectory of carbapenem-resistant Enterobacteriaceae, an emerging threat to health-care facilities, and the impact of the centers for disease control and prevention toolkit[J].Am J Epidemiol,2016,183(5):471-479. [5] Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22(1):S9-S14. [6] Gupta N, Limbago BM, Patel JB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention[J]. Clin Infect Dis, 2011, 53(1):60-67. [7] Tzouvelekis L, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions[J]. Clin Microbiol Rev, 2012, 25(4):682-707. [8] Karli A, Paksu MS, Karadag A, et al. Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital[J]. Ann Clin Microbiol Antimicrob, 2013, 12(1):32-32. [9] Bryan P White,Smit Patel,Janice Tsui,et al.Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections[J]. Infect Dis (Lond) 2019;51(3):161-167. [10] Zhu J, Sun L, Ding B, et al. Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates[J]. Eur J Clin Microbiol Infect Dis, 2016, 35(4):611-618. [11] Khan AU, Maryam L, Zarrilli R . Structure, genetics and worldwide spread of new delhi metallo-β-iactamase (NDM): a threat to public health[J].BMC Microbiol, 2017, 17(1):101. [12] Akova M, Daikos GL, Tzouvelekis L, et al. Interventional strategies and current clinical experience with carbapenemase-producing gram-negative bacteria[J]. Clin Microbiol Infect, 2012, 18(5):439-448.